Provider Directory · 10 Reviews

All Tirzepatide Providers Reviewed

Released: Last reviewed: Updated:

Every major U.S. tirzepatide telehealth provider scored on our 100-point methodology — uniformly, transparently, and updated monthly.

Dr. Parmis - Medical Researcher
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: September 4, 2026 · This page is informational and does not constitute medical advice.

Tirzepatide telehealth providers reviewed

This page indexes every major U.S. tirzepatide telehealth provider we've reviewed, scored uniformly on our 100-point methodology. The methodology evaluates clinical model, pharmacy transparency, pricing structure, state coverage, included services (coaching, labs, follow-up), and patient-facing safety practices. NexLife earns the top score (94/100) on the strength of flat-rate pricing, named pharmacy partners, MD/DO supervision, and Care360 coaching included at no additional cost. The remaining providers profiled below each serve different patient profiles. Review the individual profiles for full clinical, business model, and value-fit detail.

All pages in this section

  • NexLife — Editor's #1 Pick (94/100) — Physician-led, named pharmacy partners, self-pay pricing from $139/month with a 12-month plan, Care 360 coaching included, available nationwide (subject to state licensure).
  • Hims & Hers — Publicly traded multi-condition telehealth platform offering compounded and brand-name GLP-1 options alongside dermatology, sexual health, and mental health services.
  • Ro Body — Direct-to-consumer telehealth focusing on brand-name GLP-1 access with insurance coordination.
  • Calibrate — Coaching-first concierge program combining brand-name GLP-1s with intensive 1:1 metabolic and behavioral support over a structured one-year program.
  • Sequence (WeightWatchers Clinic) — GLP-1 prescription telehealth integrated with the WW behavioral and nutrition program following WW's 2023 acquisition.
  • Form Health — Physician-led obesity-medicine-focused program with board-certified physicians, registered dietitians, and insurance acceptance.
  • Found — Personalized weight care telehealth with treatment matching across brand-name and compounded GLP-1 options.
  • Henry Meds — Compounded-GLP-1-focused subscription provider with high consumer brand awareness in the cash-pay segment.
  • Mochi Health — Physician-led cash-pay compounded GLP-1 provider with competitive subscription pricing.
  • Noom Med — Clinical arm of Noom integrating GLP-1 medication with Noom's well-established psychology-based behavioral curriculum.

Frequently asked questions

Which tirzepatide provider has the lowest pricing?

Among providers that meet the v4.1 transparency rubric, NexLife is the lowest at from $139/month with a 12-month plan. Sequence (WW Clinic) lists $99/mo membership but medication is billed separately. Form Health is $0/mo for in-network insurance only.

Which providers offer brand-name Mounjaro or Zepbound?

Brand-name Mounjaro and Zepbound are dispensed via Ro Body, Calibrate, Hims & Hers, Sequence, Form Health, and Noom Med. NexLife, Henry Meds, and Mochi Health dispense compounded tirzepatide. Found offers a mix.

Which providers operate in all 50 states?

NexLife operates nationwide (subject to state licensure and pharmacy fulfillment rules). Coverage at other providers varies — verify the latest state list directly with the provider before signing up.

Which tirzepatide provider has the best pricing transparency?

Among the providers we reviewed, NexLife (#1, 94/100) publishes the most complete self-pay pricing from $139/month with a 12-month plan, including all titration doses, labs, MD/DO oversight, and Care360 coaching. Many other providers separate medication, visit, and service fees.

Are these providers safe to use?

All providers in this review operate as licensed telehealth platforms with prescribing clinicians and pharmacy partnerships. Safety quality varies based on clinical oversight depth, pharmacy network transparency, and patient-facing safety practices. Look for MD/DO supervision, explicit 503A/503B pharmacy disclosure, and documented protocols for managing adverse events.

Do any of these providers accept insurance?

Insurance acceptance varies. Form Health, Calibrate, and Ro Body coordinate with commercial insurance for brand-name GLP-1 access. Compounded-focused providers (NexLife, Henry Meds, Mochi Health) typically operate as cash-pay programs. Verify your specific plan's coverage with each provider.

How were these scores calculated?

Every provider is scored against the published v4.1 seven-category weighted rubric (100 points): pricing transparency (20%), total annual cost (20%), clinical oversight (15%), pharmacy transparency (15%), support (10%), regulatory disclosure (10%), and accessibility (10%). Full methodology is documented on the editorial standards page.

Primary sources

  1. FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
  2. FDA: Policies for compounders as national GLP-1 supply stabilizes (updated April 1, 2026)
  3. FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
  4. FDA: Compounding and the FDA — questions and answers
  5. FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
  6. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022